ChemPartner Establishes First European Scientific Hub at Discovery Park

Sandwich, UK — 16 April 2026: International contract research organisation ChemPartner has officially opened its first European scientific hub at Discovery Park, Sandwich, Kent. The company works with the biopharmaceutical industry to efficiently and rapidly bring life-changing drugs to market.

Founded in Shanghai in 2002, ChemPartner has more than 2,000 employees globally, most of whom are based in Asia. The company currently has seven UK employees, many of whom work hybrid, and is actively recruiting for a Senior Scientist to be based at Discovery Park. 

ChemPartner’s Discovery Park facility is a dedicated centre for preclinical and translational research, supporting drug discovery with early-stage in vitro screening and allowing for increased operational agility and accelerated timelines. The new lab has been established in collaboration with Canterbury Christ Church University, through which ChemPartner is able to access advanced laboratory equipment onsite. 

This new scientific hub marks the first step in ChemPartner’s broader UK and EU expansion, complementing the recent establishment of an R&D Centre of Excellence in Boston, USA, and the company’s established European administrative operations in Copenhagen, Denmark.

"Establishing our presence at Discovery Park reflects ChemPartner's commitment to bringing high-quality science closer to our clients," says Yinfei Yin, SVP of Biology, BD and Marketing. "This site enhances our ability to deliver responsive, integrated support across Europe, and we are excited to scale these capabilities alongside our partners."

Mayer Schreiber, CEO at Discovery Park added: “ChemPartner is exactly the kind of globally ambitious business that Discovery Park was built for. The decision to establish a first European scientific hub here is a powerful endorsement of our community, and we look forward to being part of their growth story." 

ChemPartner marked the launch of its new hub with an opening event at Discovery Park on 10 April, attended by the Global Leadership team including William Woo, CEO and Chairman of ChemPartner. 

ENDS

About ChemPartner

ChemPartner is a global preclinical CRO with expertise across all molecular modalities. The company leverages scale and a flexible partnership model to work with leading life science companies, helping them efficiently and rapidly bring life-changing drugs to market.

chempartner.com

About Discovery Park 

Discovery Park is one of the UK’s leading science and innovation campuses, providing a dynamic base for life science companies ranging from early-stage start-ups to global corporations. Located in Sandwich, Kent, with excellent connectivity to London and Europe, Discovery Park offers an ideal environment for businesses to start, scale and succeed.

With more than 180 companies on site including Pfizer, Asymchem, Cummins, ZeroAvia, GrowUp Farms, Viatris, Concept Life Sciences, Resolian, Psyros Diagnostics and York Bio, Discovery Park is home to a thriving ecosystem of innovators. The 220-acre site offers cutting-edge laboratories, flexible office and manufacturing space, and a highly supportive infrastructure tailored to the needs of science and technology businesses.

Recognised as a Life Science Opportunity Zone, Discovery Park benefits from a robust utilities infrastructure, 100% renewable electricity, and a strong pipeline of local STEM talent, underpinned by partnerships with leading academic institutions. With its strategic location, vibrant community, and access to finance through its own fund, Discovery Park Ventures, the campus plays a central role in Kent’s flourishing science and technology cluster and is an extension of the UK’s prestigious Golden Triangle.

Discover more: discovery-park.co.uk

E: info@discovery-park.co.uk, T: 01304 614060.

Media: Sophie Dufour, sophie@helix-pr.com